The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Andreeva Yu.Yu.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Vinogradov I.Iu.

GUZ "Riazanskiĭ oblastnoĭ klinicheskiĭ onkologicheskiĭ dispanser"

Glatko S.B.

GBUZ "Omskiĭ klinicheskiĭ onkologicheskiĭ dispanser"

Gorelik M.Z.

GBUZ "Primorskoe kraevoe patologoanatomicheskoe biuro", Vladivostok

Zavalishina L.É.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Leenman E.E.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr radiologii i khirurgicheskikh tekhnologiĭ" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Matsionis A.É.

GBU Rostovskoĭ oblasti "Patologoanatomicheskoe biuro", Rostov-na-Donu

Petrov S.V.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia, Elizabethan hospital, Saint-Petersburg, Russia

Sazonov S.V.

GBUZ SO "Institut meditsinskikh kletochnykh tekhnologiĭ", Ekaterinburg

10 years of testing of the HER2 status in breast cancer in Russia

Authors:

Frank G.A., Andreeva Yu.Yu., Vinogradov I.Iu., Glatko S.B., Gorelik M.Z., Zavalishina L.É., Leenman E.E., Matsionis A.É., Petrov S.V., Sazonov S.V.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2012;74(5): 3‑6

Views: 1099

Downloaded: 48

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Frank GA, Andreeva YuYu, Vinogradov IIu, et al. . 10 years of testing of the HER2 status in breast cancer in Russia. Russian Journal of Archive of Pathology. 2012;74(5):3‑6. (In Russ.)

Подписка 2025 (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Close metadata
Recommended articles:
Clinical and labo­ratory para­meters and pathomorphological features of the lungs in patients who have had COVID-19 viral pneumonia. Russian Journal of Archive of Pathology. 2024;(1):27-35
Lung pathology in children with a long-term novel coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(1):36-43
Comparative immu­nohistochemistry study of different anti­bodies clones for dete­ction of breast cancer markers (estrogen rece­ptor, progesterone rece­ptor, HER2/neu, Ki-67). Russian Journal of Archive of Pathology. 2024;(2):14-20
Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion. Russian Journal of Archive of Pathology. 2024;(2):37-41
Analysis of the work of the Immu­nohistochemical Quality Control Center of the Russian Medi­cal Academy of Continuous Professional Education of the Mini­stry of Health of Russia in 2023. Russian Journal of Archive of Pathology. 2024;(3):38-45
The role of immu­nohistochemical examination in the differential diagnosis of atypical tumors and carcinomas of para­thyroid glands. Russian Journal of Archive of Pathology. 2024;(4):5-12
Alveolar adenoma of the lung. Russian Journal of Archive of Pathology. 2024;(4):38-41
Clinical and morphological asse­ssment of combined protocol for Radiesse in dilu­tion and hardware techniques in patients with signs of chro­nological skin aging and photoaging of the face and décolleté. Plastic Surgery and Aesthetic Medi­cine. 2024;(2):38-50
Clinical and morphological aspe­cts of the use of palpebral implants made of noble metals. Russian Annals of Ophthalmology. 2024;(2-2):166-171
Precancers of the oral mucosa: clinic, diagnostics. Stomatology. 2024;(2):5-11

The paper analyzes 10 years' experience in HER2 status testing in breast cancer in Russia. The ASCO/CAP HER2 testing guidelines adaptable to the work of pathologists in Russia are considered.

Keywords:

HER2 testing
immunohistochemistry
in situ hybridization

Authors:

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Andreeva Yu.Yu.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Vinogradov I.Iu.

GUZ "Riazanskiĭ oblastnoĭ klinicheskiĭ onkologicheskiĭ dispanser"

Glatko S.B.

GBUZ "Omskiĭ klinicheskiĭ onkologicheskiĭ dispanser"

Gorelik M.Z.

GBUZ "Primorskoe kraevoe patologoanatomicheskoe biuro", Vladivostok

Zavalishina L.É.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Leenman E.E.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr radiologii i khirurgicheskikh tekhnologiĭ" Minzdravsotsrazvitiia Rossii, Sankt-Peterburg

Matsionis A.É.

GBU Rostovskoĭ oblasti "Patologoanatomicheskoe biuro", Rostov-na-Donu

Petrov S.V.

North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia, Elizabethan hospital, Saint-Petersburg, Russia

Sazonov S.V.

GBUZ SO "Institut meditsinskikh kletochnykh tekhnologiĭ", Ekaterinburg

List of references:

  1. Gershtein E.S., Kushlinskii N.E. Tkanevye markery kak faktory prognozov pri rake molochnoi zhelezy. Prakticheskaya onkologiya. 2002; 3 (1): 38-44.
  2. Zavalishina L.E., Andreeva Yu.Yu., Ryazantseva A.A., Frank G.A. Metodicheskie rekomendatsii po provedeniyu HER2-testirovaniya raka molochnoi zhelezy. Arkhiv patologii. 2011; Prilozhenie.
  3. Zavalishina L.E., Frank G.A. Morfologicheskoe issledovanie HER2-statusa raka molochnoi zhelezy. M.: Media Medica; 2010.
  4. Frank G.A., red. Rukovodstvo po interpretatsii HER2-statusa metodom in situ-gibridizatsii Ventana INFORM HER2 Dual ISH DNA Probe Cocktail Assay. M.: Rosh Diagnostika Rus; 2011.
  5. Slamon D.J., Godolphin W., Yones I.A., Holt J.A., Wong S.G., Keith D.E. et al. Studies of HER2/neu protooncogene in human breast cancer and ovarian cancer. Science. 1989; 244: 707-12.
  6. Slamon D.J., Leyland-Jones B., Shak S., Fuchs H., Paton V. Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER-2. N. Engl. J. Med. 2001; 344 (11): 783-92.
  7. Wolf A.S., Hammond M.E.H., Schwatz J.N., Hagerty K.L., Allred D.C., Cote R.J. American Society of Clinical Oncology / College of American Pathologist guideline recommendations for human epidermal growth receptor 2 testing in breast cancer. Arch. Pathol. Lab. Med. 2007; 131 (1): 18-43.
  8. Yaziji H., Goldstein L.C., Barry T.S., Werling R., Hwang H., Elis G.K. et al. HER2 testing in breast cancer using parallel tissue based methods. J. A. M. A. 2004; 291: 1972-7.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.